Cardiovascular Journal of Africa

The Pan-African Association of Structural and Coronary Interventions (PASCI); History, Mission, Organizational Structure and Core Activities for 2026-2027

Read more about PASCI, its history, mission and organisational structure, and its role in advancing coronary and structural interventions across Africa. This article explores the challenges facing interventional cardiology in Africa, PASCI’s achievements to date, and its vision for the future.

Welcome to the Cardiovascular Journal of Africa

The Cardiovascular Journal of Africa (CVJA) is an international peer-reviewed journal that keeps cardiologists up to date with advances in the diagnosis and treatment of cardiovascular disease. Topics covered include coronary disease, electrophysiology, valve disease, imaging techniques, congenital heart disease (fetal, paediatric & adult), heart failure, surgery & basic science. CVJA is the official journal of the Pan-African Society of Cardiology (PASCAR) and has been published since 1990.

If you need to refer back to the old CVJA platform, visit this link: https://cvja.co.za/index.php

Important Notice to all Authors:

Manuscript Submission Fee & Article Processing Charge (updated March 2026)


It has become necessary for the Cardiovascular Journal of Africa to charge a manuscripts submission fees for all articles submitted for publication. On acceptance of a manuscript an additional Article Processing Fee will apply before publishing.


    From the Editor-in-Chief

    Professor Paul Brink

    At the Cardiovascular Journal of Africa (CVJA), the editorial team and I are excited to welcome you to our new redesigned website. This represents a significant step forward in our ongoing mission to serve as a trusted, accessible, and comprehensive resource for the cardiovascular community across Africa and beyond.

    Our updated digital platform has been thoughtfully developed to enhance your experience whether you are reading the latest research, submitting a manuscript, or browsing through archived issues. With improved navigation, faster access to content, and mobile-friendly features, we aim to make high-quality cardiovascular knowledge more accessible than ever before.

    As a peer-reviewed and indexed journal, CVJA, continues to publish a wide range of original articles, reviews, case reports, and editorials spanning all aspects of cardiovascular medicine. From clinical practice and public health to cardiovascular imaging, surgery, and basic science, we are proud to reflect the full spectrum of inquiry that drives progress in our field.


    We invite clinicians, researchers, and scholars from across the continent and the world to engage with our content, contribute their findings, and join us in advancing cardiovascular care) through science and collaboration.

    Thank you for your continued support of CVJA. We look forward to growing together and adapting. Time does not stand still. As Bob Dylan, still around and reinventing himself, sang in the 6’s – “The Times They Are A-Changin'”

    Latest News

    Global Heart Failure Guidelines 2025 – Now Published!

    The iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025 are now available, proudly co-published by Global Cardiology and the Cardiovascular Journal of Africa. Developed by a truly international panel of experts, these guidelines address the diverse challenges of heart failure care worldwide, particularly in regions with limited healthcare resources.

    This comprehensive guideline offers updated, practical recommendations for diagnosing and managing acute and chronic heart failure, including context-specific options for both pharmacological and non-pharmacological treatment. Importantly, it introduces resource-adjusted strategies, enabling clinicians to make effective decisions even in low- and middle-income settings. By combining the latest evidence with global collaboration, these guidelines aim to reduce hospitalisations, improve outcomes, and support clinicians everywhere in delivering better heart failure care.

    Read the full guidelines here »

    Latest articles

    Clinical outcomes and haemodynamic evolution following Perceval sutureless aortic valve implantation in high-risk aortic stenosis patients

    Sutureless aortic valve replacement (AVR) has been recognised as a potential option in the management of high-risk patients, characterised by reduced procedural times and satisfactory haemodynamic results. However, mid-term results of valve-related outcomes are scarce. This study aimed to investigate clinical, echocardiographic, and valve-related outcomes of high-risk patients undergoing Perceval...

    Evaluation of six-month clinical outcomes of patients with venous thromboembolism treated with apixaban, rivaroxaban, edoxaban or dabigatran

    The advantages of direct oral anticoagulants (apixaban, rivaroxaban, edoxaban, dabigatran) over warfarin and low molecular weight heparin have been demonstrated in many studies in the treatment of patients with acute venous thromboembolism (VTE). However, a single-centre study comparing the effectiveness and safety of oral anticoagulants against each other has not yet been conducted.